New Insights into Dual-Function Proteins and Their Role in Malaria Immune Evasion and Detection

New research reveals how malaria parasites use RIFIN proteins to manipulate immune cell receptors, revealing potential targets for future malaria treatments and vaccines.
Malaria remains one of the most severe infectious diseases globally, transmitted by mosquitoes harboring Plasmodium parasites that invade human red blood cells. These infected cells are notoriously difficult for the immune system to detect and eliminate. Recent research from the University of Osaka has shed light on how malaria parasites evade immune defenses while paradoxically triggering immune responses. The study focuses on RIFIN proteins, surface molecules expressed on infected erythrocytes. These proteins can bind to killer immunoglobulin-like receptors (KIRs) on natural killer (NK) cells, which play a crucial role in identifying and destroying infected cells. Notably, RIFINs were found to interact with both inhibitory KIRs, like KIR2DL1, suppressing NK cell activity, and activating receptors, such as KIR2DS1, which promote immune response. This dual functionality suggests that RIFINs serve as both a shield and a target for immune responses, depending on which receptor they bind. The research involved screening infected cells and identifying that multiple RIFIN variants can bind to KIR2DL1, leading to NK cell inhibition and allowing the parasite to survive. Interestingly, RIFINs capable of binding to the activating KIR2DS1 were also identified, which, rather than aiding immune evasion, may help immune cells recognize and attack the parasite. The widespread presence of these RIFINs across diverse malaria strains suggests they are key players in the disease's persistence and are promising targets for future therapies. Understanding the dual role of RIFIN proteins could pave the way for novel interventions, including vaccines that can block these interactions and enhance immune responses against malaria.
Source: [https://medicalxpress.com/news/2025-06-dual-function-proteins-clues-immune.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Technology Identifies Breast Cancer Relapses up to Five Years Early
A novel blood test developed by Altum Sequencing can predict breast cancer relapse up to five years in advance, revolutionizing post-treatment monitoring and early intervention strategies.
New Regulations for Cosmetic Injectables: Enhancing Industry Safety
Australia has introduced new safety regulations for cosmetic injectables to combat unsafe practices, unethical promotion, and inadequate practitioner training, aiming to protect patients and elevate industry standards.
New Daily Oral Medication for Endometriosis Soon Available on the NHS: How Linzagolix Works
A new oral medication, linzagolix, has been recommended by NICE for the treatment of endometriosis. This innovative drug offers hope for women suffering from painful symptoms and infertility, providing a tailored, reversible, and effective option when other treatments fail.